These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 10608022)

  • 21. Complement, neutrophils and free radicals: mediators of reperfusion injury.
    Lucchesi BR
    Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?
    Heper G; Korkmaz ME; Kilic A
    Angiology; 2007 Dec-2008 Jan; 58(6):663-70. PubMed ID: 17989422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodromal angina limits infarct size. A role for ischemic preconditioning.
    Ottani F; Galvani M; Ferrini D; Sorbello F; Limonetti P; Pantoli D; Rusticali F
    Circulation; 1995 Jan; 91(2):291-7. PubMed ID: 7805230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen-derived free radicals and postischemic myocardial reperfusion: therapeutic implications.
    Richard VJ; Murry CE; Jennings RB; Reimer KA
    Fundam Clin Pharmacol; 1990; 4(1):85-103. PubMed ID: 2187785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on.
    Baxter GF
    Basic Res Cardiol; 2002 Jul; 97(4):268-75. PubMed ID: 12111036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reperfusion Injury: Basic Concepts and Protection Strategies.
    Kukreja RC; Janin Y
    J Thromb Thrombolysis; 1997 Jan; 4(1):7-24. PubMed ID: 10639218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary cyclic flow variations "precondition" ischemic myocardium.
    Ovize M; Kloner RA; Hale SL; Przyklenk K
    Circulation; 1992 Feb; 85(2):779-89. PubMed ID: 1735170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.
    Halladin NL
    Dan Med J; 2015 Apr; 62(4):B5054. PubMed ID: 25872540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free radicals and myocardial ischemia and reperfusion injury.
    Simpson PJ; Lucchesi BR
    J Lab Clin Med; 1987 Jul; 110(1):13-30. PubMed ID: 3298506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preconditioning does not attenuate myocardial stunning.
    Ovize M; Przyklenk K; Hale SL; Kloner RA
    Circulation; 1992 Jun; 85(6):2247-54. PubMed ID: 1591839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.
    Litt MR; Jeremy RW; Weisman HF; Winkelstein JA; Becker LC
    Circulation; 1989 Dec; 80(6):1816-27. PubMed ID: 2598440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of ischemia--reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE).
    Ozer MK; Parlakpinar H; Acet A
    Clin Biochem; 2004 Aug; 37(8):702-5. PubMed ID: 15302615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial ischemia and reperfusion.
    Jennings RB; Steenbergen C; Reimer KA
    Monogr Pathol; 1995; 37():47-80. PubMed ID: 7603485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reperfusion injury: experimental evidence and clinical implications.
    Ambrosio G; Tritto I
    Am Heart J; 1999 Aug; 138(2 Pt 2):S69-75. PubMed ID: 10426862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review.
    Vaage J; Valen G
    Scand J Thorac Cardiovasc Surg Suppl; 1993; 41():1-18. PubMed ID: 8184289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic heart disease and antioxidants: mechanistic aspects of oxidative injury and its prevention.
    Janero DR
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):65-81. PubMed ID: 7748481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.